Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

NCT06382818 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
854
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle